EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, cilt.64, sa.9, ss.889-894, 2008 (SCI-Expanded)
Objectives The objective of this study was to determine the quantitative influence of vitamin K epoxide reductase complex subunit 1 (VKORC1) and cytochrome P450 2C9 (CYP 2C9) polymorphisms on warfarin dose requirements in Turkish patients.